Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Free Cash Flow (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Free Cash Flow data on record, last reported at $53.5 million in Q4 2025.

  • For Q4 2025, Free Cash Flow rose 253.66% year-over-year to $53.5 million; the TTM value through Dec 2025 reached $74.0 million, changed N/A, while the annual FY2025 figure was $80.7 million, 132.64% up from the prior year.
  • Free Cash Flow reached $53.5 million in Q4 2025 per CAI's latest filing, down from $55.3 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $55.3 million in Q3 2025 and bottomed at -$71.3 million in Q3 2024.